Michael Busse

606 total citations
25 papers, 469 citations indexed

About

Michael Busse is a scholar working on Neurology, Cognitive Neuroscience and Epidemiology. According to data from OpenAlex, Michael Busse has authored 25 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Cognitive Neuroscience and 5 papers in Epidemiology. Recurrent topics in Michael Busse's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Diabetes Treatment and Management (4 papers). Michael Busse is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers) and Diabetes Treatment and Management (4 papers). Michael Busse collaborates with scholars based in Germany, United Kingdom and United States. Michael Busse's co-authors include Ramiro Castro, Jules H. Schagen van Leeuwen, Bart L.H. Bemelmans, Werner Poewe, Olivier Rascol, Anthony H.V. Schapira, Yoshikuni Mizuno, Paolo Barone, Robert A. Hauser and Mandy Fraessdorf and has published in prestigious journals such as Neurology, European Urology and Neuropharmacology.

In The Last Decade

Michael Busse

23 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Busse Germany 11 209 171 141 82 62 25 469
Camilla Rocchi Italy 10 129 0.6× 71 0.4× 84 0.6× 54 0.7× 60 1.0× 19 322
W. Greulich Germany 10 200 1.0× 73 0.4× 67 0.5× 24 0.3× 22 0.4× 25 351
J.A.M. Nóbrega Brazil 12 110 0.5× 18 0.1× 91 0.6× 38 0.5× 43 0.7× 41 447
Tannaz Ahadi Iran 16 91 0.4× 20 0.1× 48 0.3× 79 1.0× 72 1.2× 51 597
George Tharion India 13 51 0.2× 25 0.1× 26 0.2× 33 0.4× 21 0.3× 40 508
Annabelle Couillandre France 10 164 0.8× 16 0.1× 39 0.3× 16 0.2× 53 0.9× 22 422
H.E. van der Aa Netherlands 10 71 0.3× 12 0.1× 109 0.8× 111 1.4× 76 1.2× 14 348
Peter K.W. Lee South Korea 9 165 0.8× 61 0.4× 137 1.0× 13 0.2× 7 0.1× 9 608
Christine Hazelton United Kingdom 14 42 0.2× 328 1.9× 370 2.6× 19 0.2× 56 0.9× 22 720
Peter T. Dorsher United States 12 19 0.1× 29 0.2× 100 0.7× 88 1.1× 65 1.0× 36 495

Countries citing papers authored by Michael Busse

Since Specialization
Citations

This map shows the geographic impact of Michael Busse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Busse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Busse more than expected).

Fields of papers citing papers by Michael Busse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Busse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Busse. The network helps show where Michael Busse may publish in the future.

Co-authorship network of co-authors of Michael Busse

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Busse. A scholar is included among the top collaborators of Michael Busse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Busse. Michael Busse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Busse, Michael, et al.. (2019). DPP-4 Inhibitor Dose Selection According to Manufacturer Specifications: A Contemporary Experience From UK General Practice. Clinical Therapeutics. 41(8). 1622–1630. 2 indexed citations
2.
Okhai, Hajra, et al.. (2019). Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study. Diabetes Obesity and Metabolism. 21(8). 1817–1823. 6 indexed citations
3.
Barrett, Brendan J., et al.. (2018). Prescription of DPP-4 Inhibitors to Patients With Adult Type 2 Diabetes Mellitus and Creatinine Clearance >50 mL/min: The UK Primary Care Experience. Clinical Therapeutics. 40(8). 1424–1428.e4. 1 indexed citations
4.
Barrett, Brendan J., et al.. (2017). Prescription of DPP-4 Inhibitors to Type 2 Diabetes Mellitus Patients With Renal Impairment: A UK Primary Care Experience. Clinical Therapeutics. 40(1). 152–154. 8 indexed citations
5.
Hauser, Robert A., Anthony H.V. Schapira, Paolo Barone, et al.. (2014). Long‐term safety and sustained efficacy of extended‐release pramipexole in early and advanced Parkinson's disease. European Journal of Neurology. 21(5). 736–743. 26 indexed citations
6.
Strauß, Daniel J., Michael Busse, David R. Stevens, et al.. (2013). Estimating the modulatory effects of nanoparticles on neuronal circuits using computational upscaling. International Journal of Nanomedicine. 8. 3559–3559. 3 indexed citations
7.
Pei, Xianqiang, Roland Bennewitz, Michael Busse, & Alois K. Schlarb. (2013). Effects of single asperity geometry on friction and wear of PEEK. Wear. 304(1-2). 109–117. 20 indexed citations
8.
Schapira, Anthony H.V., Paolo Barone, Robert A. Hauser, et al.. (2012). Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease. European Journal of Neurology. 20(1). 50–56. 18 indexed citations
9.
Högl, Birgit, Diego García‐Borreguero, Claudia Trenkwalder, et al.. (2011). Efficacy and augmentation during 6months of double-blind pramipexole for restless legs syndrome. Sleep Medicine. 12(4). 351–360. 69 indexed citations
10.
Hornyak, Magdolna, Mandy Sohr, & Michael Busse. (2011). Evaluation of painful sensory symptoms in restless legs syndrome: Experience from two clinical trials. Sleep Medicine. 12(2). 186–189. 25 indexed citations
11.
Poewe, W., Paolo Barone, R. Hauser, et al.. (2011). 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE. Parkinsonism & Related Disorders. 18. S131–S132. 1 indexed citations
12.
Busse, Michael, Mathias Vukelić, Annette Kraegeloh, et al.. (2011). On the possible effects of nanoparticles on neuronal feedback circuits: A modeling study. 22. 136–139.
13.
Schapira, Anthony H.V., Paolo Barone, Y Mizuno, et al.. (2010). Sustained efficacy and tolerability of pramipexole extended-release as adjunctive treatment in advanced Parkinson's disease. UCL Discovery (University College London). 1 indexed citations
14.
Busse, Michael, Annette Kraegeloh, David R. Stevens, et al.. (2010). Modeling the effects of nanoparticles on neuronal cells: From ionic channels to network dynamics. PubMed. 6. 3816–3819. 8 indexed citations
15.
Busse, Michael, et al.. (2009). Assessment of aversive stimuli dependent attentional binding by the N170 VEP component. PubMed. 119. 3975–3978. 5 indexed citations
16.
Busse, Michael, Yin Fen Low, Farah I. Corona–Strauss, W. Delb, & Daniel J. Strauß. (2008). Neurofeedback by neural correlates of auditory selective attention as possible application for tinnitus therapies. PubMed. 2008. 5136–5139. 10 indexed citations
17.
Leeuwen, Jules H. Schagen van, Ramiro Castro, Michael Busse, & Bart L.H. Bemelmans. (2006). The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms. European Urology. 50(3). 440–453. 102 indexed citations
18.
Gross, Andreas J., et al.. (2005). Switch from phytotherapy to tamsulosin in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Prostate Cancer and Prostatic Diseases. 8(3). 210–214. 2 indexed citations
19.
Thomas, Michaël, et al.. (2003). Normalwerte der Schulterkraft in Abhängigkeit von Alter und Geschlecht - Vergleich zum Constant-, UCLA-, ASES-Score und SF-36 Fragebogen. Zeitschrift für Orthopädie und ihre Grenzgebiete. 141(2). 160–170. 36 indexed citations
20.
Dawirs, R. R., Gertraud Teuchert‐Noodt, & Michael Busse. (1991). Single doses of methamphetamine cause changes in the density of dendritic spines in the prefrontal cortex of gerbils (Meriones unguiculatus). Neuropharmacology. 30(3). 275–282. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camilla Rocchi Breakdown of academic impact, for papers by W. Greulich Breakdown of academic impact, for papers by J.A.M. Nóbrega Breakdown of academic impact, for papers by Tannaz Ahadi Breakdown of academic impact, for papers by George Tharion Breakdown of academic impact, for papers by Annabelle Couillandre Breakdown of academic impact, for papers by H.E. van der Aa Breakdown of academic impact, for papers by Peter K.W. Lee Breakdown of academic impact, for papers by Christine Hazelton Breakdown of academic impact, for papers by Peter T. Dorsher
Rankless by CCL
2026